First-ever live conference on cancer awareness held in J-K

Jammu (Jammu and Kashmir) [India]: In order to promote awareness on cancer, a 24-hour live video conference workshop was held in Jammu, as part of a two-day cancer awareness program.

Crabethon is the first-of-its-kind live conference aimed at assisting common people to connect with oncologists and specialists around the world in order to discuss the dreaded disease.

Deepak Abrol, the Convener of this event, said that about 60 per cent of cancer is preventable, provided people adopt healthy lifestyles. He added that leaving tobacco and controlling Human Papillomavirus and Hepatitis B through vaccination programs can also help reduce the spread of cancer.

Speaking to ANI, Abrol said that spreading awareness is the only way to get rid of the stigma attached to the disease. He also said that the awareness drive will go a long way to help people realise that Cancer, like any other disease, is treatable and curable at the same time.

A studio was created for people to interact live with a panel of experts through live streaming on various social media channels.

A participant, Anil Dhar, who attended the event said that the perception about cancer needs to change amongst people through such awareness campaigns.

Over 50 oncologists from all over India are attending the event, which is slated to be held until the end of today.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre